Pasireotide diaspartate

Definition: Pasireotide, sold under the brand name Signifor, is an orphan drug approved in the United States and the European Union for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs. source: Wikipedia

ID

704269005

ID date

2 Apr 2015

Previous ID

21217411000001103

Name

Pasireotide diaspartate